This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2023 Jan;19(3):271.

doi: 10.2217/fon-2022-0456c1. Epub 2023 Jan 19.

No authors listed

Published Erratum

No authors listed. Future Oncol. 2023 Jan.

. 2023 Jan;19(3):271.

doi: 10.2217/fon-2022-0456c1. Epub 2023 Jan 19.

No abstract available

MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Ryan CE, Davids MS, Hermann R, Shahkarami M, Biondo J, Abhyankar S, Alhasani H, Sharman JP, Mato AR, Roeker LE. Ryan CE, et al. Future Oncol. 2022 Oct;18(33):3689-3699. doi: 10.2217/fon-2022-0456. Epub 2022 Sep 14. Future Oncol. 2022. PMID: 36102212